23284-18-6

Basic information

• Product Name: PELTATOSIDE
• Synonyms: PELTATOSIDE;QUERCETIN 3-ARABINOGLUCOSIDE;QUERCETIN-3-O-ARABINOGLUCOSIDE;3-[(6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one;PELTATOSIDE hplc;PELTATOSIDE WITH HPLC;3-[(6-O-α-L-Arabinopyranosyl-β-D-glucopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-5,6-dihydroxy-4H-1-benzopyran-4-one;PELARGONIDIN-3,5-DIGLUCOSIDE(PELARGONIN CHLORIDE(RG)
• CAS NO: 23284-18-6
• Molecular Formula: C₂₆H₂₈O₁₆
• Molecular Weight: 596.49
• EINECS: 245-555-1
• Product Categories: Flavanols;reagent
• Mol File: 23284-18-6.mol
• Article Data: 2

Chemical Properties

• Melting Point: 210°C (dec.)
• Boiling Point: 994.8°Cat760mmHg
• Flash Point: 331.8°C
• Appearance: /
• Density: 1.87g/cm³
• PKA: 6.17±0.40(Predicted)
• CAS DataBase Reference: PELTATOSIDE(CAS DataBase Reference)
• NIST Chemistry Reference: PELTATOSIDE(23284-18-6)
• EPA Substance Registry System: PELTATOSIDE(23284-18-6)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 23284-18-6(Hazardous Substances Data)

Usage

Description

Peltatoside is a natural compound derived from the leaves of Annona crassiflora Mart., a plant that has been traditionally utilized in folk medicine. It is an analogue of quercetin, a flavonoid known for its wide range of biological activities, such as analgesic effects.

Uses

Used in Pharmaceutical Applications:
PELTATOSIDE is used as a potential therapeutic agent for various medical conditions due to its quercetin-like properties. Its flavonoid nature suggests that it may have beneficial effects on human health, including analgesic and anti-inflammatory actions.
Used in Anticancer Applications:
PELTATOSIDE is used as an inhibitor of Leishmania major dihydroorotate dehydrogenase, which is an essential enzyme in the pyrimidine biosynthesis pathway. This inhibition can potentially lead to the development of new treatments for Leishmaniasis, a disease caused by protozoan parasites of the genus Leishmania.
Used in Drug Delivery Systems:
PELTATOSIDE may be used in the development of novel drug delivery systems to enhance its bioavailability and therapeutic outcomes. By employing various organic and metallic nanoparticles as carriers, the delivery, efficacy, and overall performance of PELTATOSIDE in treating specific conditions can be improved.
Used in Antiviral Applications:
PELTATOSIDE's potential antiviral properties, due to its quercetin-like nature, can be explored for the development of new antiviral drugs. This application could be particularly relevant in the context of emerging viral diseases and the ongoing need for new therapeutic options.
Used in Nutraceutical Applications:
Given its flavonoid content, PELTATOSIDE may also be used in the development of nutraceutical products, which are substances that provide medical or health benefits, including the prevention and treatment of diseases. These products could include dietary supplements, functional foods, and beverages enriched with PELTATOSIDE for their potential health-promoting properties.

Upstream product

• 1374260-02-2 quercetin 3-O-[4'''-O-acetyl-α-L-arabinopyranosyl]-(1'''->6'')-β-D-galactopyranoside 

Downstream Products

• 131981-37-8 3''-O-butanoylpeltatoside 
• 131981-36-7 4'''-O-butanoylpeltatoside 
• 131981-38-9 3'',4'''-di-O-butanoylpeltatoside 
• 5328-37-0 L-arabinose 
• 59-23-4 D-Galactose 
• 117-39-5 quercetol 

Relevant articles and documents

A new flavonol glycoside from Hylomecon vernalis

Purification of a MeOH extract from the aerial parts of Hylomecon vernalis Maxim. (Papaveraceae) using column chromatography furnished a new acetylated flavonol glycoside (1), together with twenty known phenolic compounds (2-21). Structural elucidation of 1 was based on 1D- and 2D-NMR spectroscopy data analysis to be quercetin 3-O-[4′→O-acetyl-α-L-arabinopyranosyl] -( 1′→6′)-β-D-galactopyranoside (1). The structures of compounds 2-21 were elucidated by spectroscopy and confirmed by comparison with reported data; quercetin 3-O- [2′→O-acetyl-α-L- arabinopyranosyl]-(1′→6′)-β-D-galactopyranoside (2), quercetin 3-O-α-L-arabinopyranosyl-( 1′→6′)-β-D- galactopyranoside (3), quercetin 3-O-β-D-galactopyranoside (4), kaempferol 3,7-O-α-L-dirhamnopyranoside (5), diosmetin 7-O-β-D-glucopyranoside (6), diosmetin 7-O-β-D-xylopyranosyl-(1′→6′)-β-D- glucopyranoside (7), p-hydroxybenzoic acid (8), protocatechuic acid (9), caffeic acid (10), 6-hydroxy-3,4-dihydro-1-oxo-β-carboline (11), (Z)-3- hexenyl-β-D-glucopyranoside (12), (E)-2-hexenyl-β-D-glucopyranoside (13), (Z)-3-hexenyl-α-Larabinopyranosyl-( 1′→6')-β-D- glucopyranoside (14), oct-1-en-3-yl-α-L-arabinopyranosyl- (1′→6')- β-D-glucopyranoside (15), benzyl-β-D- apiofuranosyl-(1′→6')-β-D-glucopyranoside (16), benzyl- α-L-arabinopyranosyl-(1′→6')-β-D-glucopyranoside (17), benzyl-β-D-xylopyranosyl-(1′→6')-β-Dglucopyranoside (18), 2-phenylethyl-α-L-arabinopyranosyl-(1′→6')-β-D- glucopyranoside (19), 2-phenylethyl-β-D-apiofuranosyl-(1′→6')- β-D-glucopyranoside (20), and aryl-β-D-glucopyranoside (21). Compounds 2-21 were isolated for the first time from this plant. The isolated compounds were tested for cytotoxicity against four human tumor cell lines in vitro using a Sulforhodamin B bioassay.